Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. VVOS
VVOS logo

VVOS

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VVOS News

Vivos Therapeutics Reports 16% Revenue Growth in 2025

4d agoYahoo Finance

Vivos Therapeutics Reports Increased Annual Loss

4d agoNASDAQ.COM

Vivos Therapeutics Q4 2025 Earnings Call Insights

4d agoseekingalpha

Vivos Therapeutics Reports Disappointing Earnings

5d agoseekingalpha

VIVOS THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE FULL YEAR 2025

5d agomoomoo

New Show to Air Tonight on Bloomberg Television

Feb 21 2026Yahoo Finance

Vivos Partners with SoundHealth to Launch Innovative Sleep Solutions

Feb 05 2026Newsfilter

Oversold Stocks in Healthcare Sector Present Buying Opportunities

Feb 03 2026Benzinga

Vivos Therapeutics Closes Exercise of 1.98M Warrants, Raising $4.64M

Jan 20 2026Globenewswire

Vivos Therapeutics (VVOS) Exercises Warrants for $4.64M in Funding

Jan 16 2026seekingalpha

Vivos Therapeutics CEO and CFO to Discuss Strategic Business Model on December 16, 2025

Dec 15 2025Globenewswire

Vivos Therapeutics Hosts Strategic Discussion on OSA Market Opportunities

Dec 15 2025Newsfilter

Vivos Therapeutics Sees Major Revenue Increase in Q3 2025

Nov 19 2025Newsfilter

Alto Neuroscience Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Monday

Nov 17 2025Benzinga

Biotech Surge on Friday: Clinical Advancements Drive Afternoon Gains

Sep 29 2025NASDAQ.COM

Vivos Therapeutics Introduces Innovative Model

Aug 19 2025NASDAQ.COM